Yes DD I agree. Pretty silly post. About as silly as some of the tweets coming from AF, PC, and others. Does AF really think they are still looking for the money to run the trial? Pretty naive statement. And PC comment about the cancer patients thinking twice about enrolling. So they should think twice about choosing a drug that could possibly double their survival and at worst is the current SOC. Very solid logic. Is this the type of great minds that exist in your circle?
Market Data 
Markets 
AI
